Stay updated on Lorlatinib After First-line TKI Failure in ROS1 NSCLC Clinical Trial

Sign up to get notified when there's something new on the Lorlatinib After First-line TKI Failure in ROS1 NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lorlatinib After First-line TKI Failure in ROS1 NSCLC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Added a new version entry: Revision: v3.5.0, and removed the entry: Revision: v3.4.3, in the study record history.
    Difference
    0.1%
    Check dated 2026-03-25T01:36:06.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Revision v3.4.3 was added to the history and revision v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-10T14:40:56.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The history shows a new revision entry (v3.4.2) and removal of the previous revision (v3.4.1); this is metadata about page revisions and does not alter study information or display.
    Difference
    0.1%
    Check dated 2026-02-17T03:23:42.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The History page now shows Revision: v3.4.1 added and Revision: v3.4.0 removed, a minor update to the version history display (To avoid being alerted by small changes, set an alert condition by clicking below).
    Difference
    0.1%
    Check dated 2026-02-09T22:59:59.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Added a banner stating that information may not be up to date due to a lapse in government funding. It notes that the NIH Clinical Center is open and provides links to cc.nih.gov and opm.gov for status updates.
    Difference
    0.7%
    Check dated 2026-02-02T21:28:12.000Z thumbnail image
  8. Check
    69 days ago
    Change Detected
    Summary
    The page now shows a glossary toggle, color-code explanations for changes (green/red highlights), a new revision label (v3.4.0), and removal of the 'No FEAR Act Data' item. These updates do not modify study data, eligibility, or results on the page; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    1%
    Check dated 2026-01-26T19:47:20.000Z thumbnail image

Stay in the know with updates to Lorlatinib After First-line TKI Failure in ROS1 NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lorlatinib After First-line TKI Failure in ROS1 NSCLC Clinical Trial page.